Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 18,808,000 | 17,715,000 | 15,617,000 | 16,208,000 | 18,605,000 |
| Cost of Goods | 5,140,000 | 5,316,000 | 4,919,000 | 5,420,000 | 5,737,000 |
| Gross Profit | 13,668,000 | 12,399,000 | 10,698,000 | 10,788,000 | 12,868,000 |
| Operating Expenses | 8,348,000 | 8,887,000 | 8,505,000 | 9,016,000 | 9,166,000 |
| Operating Income | 5,320,000 | 3,512,000 | 2,193,000 | 1,772,000 | 3,702,000 |
| Other Income | 282,000 | 1,264,000 | 330,000 | 313,000 | 602,000 |
| Pre-tax Income | 5,602,000 | 4,776,000 | 2,523,000 | 2,085,000 | 4,304,000 |
| Income Tax | 1,182,000 | 1,090,000 | 471,000 | 431,000 | 870,000 |
| Net Income Continuous | 4,420,000 | 3,686,000 | 2,052,000 | 1,214,000 | 2,842,000 |
| Net Income Discontinuous | 7,442,000 | 2,557,000 | 876,000 | 371,000 | 158,000 |
| Minority Interests | 1,250,000 | 996,000 | 763,000 | N/A | N/A |
| Net Income | $10,612,000 | $5,247,000 | $2,165,000 | $1,585,000 | $3,000,000 |
| EPS Basic Total Ops | 5.35 | 2.64 | 1.09 | 0.81 | 1.53 |
| EPS Basic Continuous Ops | 1.63 | 1.36 | 0.65 | 0.62 | 1.45 |
| EPS Basic Discontinuous Ops | 3.72 | 1.28 | 0.44 | 0.19 | 0.08 |
| EPS Diluted Total Ops | 5.34 | 2.62 | 1.09 | 0.81 | 1.52 |
| EPS Diluted Continuous Ops | 1.63 | 1.35 | 0.65 | 0.62 | 1.44 |
| EPS Diluted Discontinuous Ops | 3.71 | 1.27 | 0.44 | 0.19 | 0.08 |
| EBITDA(a) | $6,027,000 | $4,328,000 | $3,085,000 | $2,699,000 | $4,631,000 |